Search

everythinglearnresearchcommunity

for

Search:↓

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

Steroid injections are more effective than platelet rich plasma for treating patchy hair loss.

Hair loss in children is often caused by scalp infections, immune disorders, hair pulling, stress, and requires careful treatment due to emotional effects.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

Topical corticosteroids are the best initial treatment for children's alopecia areata.

The research suggests that autophagy-related genes might play a role in causing alopecia areata.

An infant with complete hair loss was diagnosed with a genetic disorder affecting hair growth.

Herbal treatments are effective and preferred for hair loss with fewer side effects.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Baricitinib may effectively treat nail changes in alopecia areata.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

Nivolumab can cause hair loss as a rare side effect.

More research is needed to understand the genetic causes of Alopecia areata to develop better treatments.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

Alopecia areata greatly affects people's life quality, mental health, and work life.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

A man with severe hair loss regrew all his hair using tofacitinib and stayed healthy for a year.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Combining triamcinolone acetonide and immunotherapy can help regrow hair in some alopecia totalis patients.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Traditional treatment for pediatric alopecia areata is most effective and should be first choice.

Minoxidil 2% is more effective than tacrolimus 0.1% for hair regrowth in mild to moderate patchy hair loss, and combining both might give better results.

Nutricosmetics with active ingredients can help with hair loss and improve hair growth.